Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

Alphabet (GOOGL) is expected to release its fourth-quarter earnings results after the closing bell on Tuesday.

Not many children dream of winning a Nobel Prize when they grow up, but Demis Hassabis did. And win it, he did. In October 2024, the British co-founder and chief executive officer of Google ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

AI has already disrupted fields like coding, investment banking and law, but it looks to be poised to change yet another ...

Isomorphic Labs, the four-year-old drug discovery start-up owned by Google parent Alphabet ... says its founder Sir Demis Hassabis. “We’re looking at oncology, cardiovascular ...

Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in Anthropic, a ...

Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...